… Board (SAB). In vivo proof of concept data for novel Axiomer ® RNA editing platform technology presented at the … 1/2 trial of QR-110, announcing the in vivo PoC for our Axiomer technology and the completion of the pre-clinical … programs and our novel RNA-editing technology, Axiomer ® . We are also thrilled with the spin out of Amylon …
… N.V. entered into a research collaboration to apply the Axiomer ® RNA editing technology to fibrosis targets selected … research collaboration with Galapagos, where the company’s Axiomer ® technology will be applied to certain fibrosis … partnering and other strategic relationships for the Axiomer ® platform in select therapeutic areas Entered into a …
… Scientific Officer role, with leadership oversight of Axiomer ® RNA-editing platform technology John Maraganore, … to provide strategic oversight of ProQR’s proprietary Axiomer RNA-editing platform technology. He is the scientific … new strategy, including further building out the Company’s Axiomer RNA-editing technology as a value-generating …
… X: Late-breaking clinical studies Poster presentation on Axiomer ® RNA editing technology A presentation will be … PhD, Sr. scientist computational analytics of ProQR on the Axiomer ® RNA editing technology. Poster title: … Western world have LCA10 because of this mutation. About Axiomer ® Technology Platform ProQR is pioneering a …